Tscan Therapeutics Inc (TCRX)

Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	92.15% 0.566	7.211	3.887	3.148	6.803
Operating Expenses	11.80% 31.94	28.57	28.64	27.76	29.55
Interest Income/Expense	12.56% 0.959	0.852	0.982	0.969	0.956
Benefits Costs and Expenses	14.48% 30.71	26.82	-	-	29.37
Costs And Expenses	14.48% 30.71	26.82	28.64	27.76	29.37
Operating Income/Loss	46.90% -31.37	-21.36	-24.75	-24.61	-22.74
Income/Loss From Continuing Operations Before Tax	53.68% -30.14	-19.61	3.887	3.148	-22.56
Income/Loss From Continuing Operations After Tax	53.68% -30.14	-19.61	-23.00	-24.05	-22.56
Net Income/Loss	53.68% -30.14	-19.61	-23.00	-24.05	-22.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	859.45% 94.88	9.8886	94.83	47.21	24.23
Diluted Average Shares	859.45% 94.88	9.8886	94.83	47.21	24.23
Basic Earnings Per Share	190.91% -0.32	-0.11	-0.24	-0.51	-0.93
Diluted Earnings Per Share	190.91% -0.32	-0.11	-0.24	-0.51	-0.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-